Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
Table 1
Characteristics of the study population.
Variables
Sulodexide group ()
Control group ()
value
Age (yrs)
0.330
Male (%)
32 (61.5%)
37 (66.1%)
0.329
Body weight (kg)
0.336
Systolic blood pressure (mmHg)
0.136
Diastolic blood pressure (mmHg)
0.289
Comorbid disease (%)
Hypertension
48 (92.3%)
50 (89.2%)
0.246
Dyslipidemia
48 (92.3%)
51 (91.1%)
0.314
Cerebrovascular disease
7 (13.4%)
5 (8.9%)
0.165
Coronary heart disease
12 (23.1%)
16 (28.6%)
0.426
BUN (mg/dL)
0.314
Serum creatinine (mg/dL)
0.658
Glomerular filtration rate (mL/min/1.73 m2)
0.597
Urine protein creatinine ratio (g/gCr)
0.66 (0.23, 0.67)
0.90 (0.3, 1.78)
0.857
Fasting plasma glucose (mg/dL)
0.804
Hemoglobin A1C (%)
0.703
ACEIs/ARBs use (, %)
43 (82.7%)
49 (87.5%)
0.418
Statins (, %)
39 (75.0%)
38 (67.8%)
0.121
Data presents as mean with SD, median with interquartile range (IQR) and percentage. ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; BUN: blood urea nitrogen.
